Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis.
about
Advances in the prevention, management, and treatment of community-acquired pneumoniaPrognostic value of procalcitonin in pneumonia: A systematic review and meta-analysisComparison of CATs, CURB-65 and PMEWS as triage tools in pandemic influenza admissions to UK hospitals: case control analysis using retrospective dataFailure of CRP decline within three days of hospitalization is associated with poor prognosis of Community-acquired PneumoniaModified IDSA/ATS Minor Criteria for Severe Community-Acquired Pneumonia Best Predicted MortalityRisk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysisComparison of three predictive rules for assessing severity in elderly patients with CAP.Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort studyImprovement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia.Severity assessment of lower respiratory tract infection in Malawi: derivation of a novel index (SWAT-Bp) which outperforms CRB-65.Defining severe pneumonia.The Pneumonia Severity Index as a Predictor of In-Hospital Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseSerum iron and A(2)DS(2) score in stroke-associated pneumoniaThe International Community-Acquired Pneumonia (CAP) Collaboration Cohort (ICCC) study: rationale, design and description of study cohorts and patients.Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis.Predicting the Risk of Readmission in Pneumonia. A Systematic Review of Model PerformanceGuidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.Predicting mortality with severity assessment tools in out-patients with community-acquired pneumonia.Statins and associated risk of pneumonia: a systematic review and meta-analysis of observational studies.Predicting ICU admission in community-acquired pneumonia: clinical scores and biomarkers.Functional status and mortality prediction in community-acquired pneumonia.Can we improve clinical outcomes in patients with pneumonia treated with antibiotics in the intensive care unit?Mortality prediction using serum biomarkers and various clinical risk scales in community-acquired pneumonia.Soluble thrombomodulin to evaluate the severity and outcome of community-acquired pneumonia.Neutrophil-To-Lymphocyte Ratio: An Emerging Marker Predicting Prognosis in Elderly Adults with Community-Acquired Pneumonia.Blood culture fluorescence rates predict severity and mortality of invasive pneumococcal pneumonia.CURB-65 and other markers of illness severity in community-acquired pneumonia among HIV-positive patients.[Risk scores for community acquired pneumonia in elderly and geriatric patients].Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia.Short-term mortality of adult inpatients with community-acquired pneumonia: external validation of a modified CURB-65 score.Assessment of oxygenation and comorbidities improves outcome prediction in patients with community-acquired pneumonia with a low CRB-65 score.Risk prediction models for mortality in community-acquired pneumonia: a systematic review.Fatty acid-binding proteins as diagnostic and prognostic markers in pneumonia.The usefulness of confusion, urea, respiratory rate, and shock index or adjusted shock index criteria in predicting combined mortality and/or ICU admission compared to CURB-65 in community-acquired pneumonia.Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017.Reply to: Neutrophil to Lymphocyte Ratio As a Risk Stratification Tool for Older Adults with Pneumonia.Development of a prediction tool for patients presenting with acute cough in primary care: a prognostic study spanning six European countries.Severity assessment for lower respiratory tract infections: potential use and validity of the CRB-65 in primary care
P2860
Q26753138-6C0B882C-F08B-474D-80CE-88C082147BD9Q26776356-FD5722DE-04ED-4FED-9831-6A5A249699AFQ28730789-5C2B5530-D489-41EF-81A4-D4B19B5AA2C9Q30160730-EF602A08-61E3-4736-9017-34F9A336BD12Q33425748-89403767-DB78-4FEF-A066-7B8A1D2BC5EBQ33604883-76B92890-AC5F-4E20-B14F-DA76E80539E9Q34032698-659E3DF9-64A4-4CDF-8251-62293BF8E446Q34231948-37CE8D1D-BA5F-413B-A846-CB9D207A9A79Q34419979-ABF694E4-F1FF-4692-BFA1-15FA6031D75AQ35064123-5F095966-691B-4683-9EA6-49FBDAFBF4D4Q35184605-1C0E8C4C-03B9-4917-A02B-BD262F321D63Q35695038-5248E475-6021-46E5-86FC-ED89852CA287Q35792011-6BE15CB4-BE6D-422D-889D-3DEFED5CCC0DQ35981786-A43D015A-E0EA-4F38-9896-CF241853451AQ36031663-D2A6B7E3-7D78-4C1A-99A7-D409967E3E1AQ36051646-FFC244B7-8E28-4422-B59A-16DFA2F11CB8Q36281234-705D56DE-73B5-4FCD-B8CF-2A7C514268CFQ37902371-D386FECC-3F13-4D65-A6BE-E9A44BB2C79EQ37956128-4BE0C152-F7BD-49F2-B98A-1B5E80C51FBBQ38040130-F8A231A6-984B-4AD0-9900-7195CBA4057FQ38780796-B5C3A729-8532-49B0-B331-34D09A75C57BQ38835029-58875F13-19AA-4DA8-ADC1-A54E92F7DCC1Q40147071-3A0A465D-8830-42F6-966B-5C89EBB3D4CEQ40173806-41C99668-F407-43F8-8A8F-073A00621DF0Q40243653-97490137-FDCC-4A5E-A4E6-931E46D4D330Q40986030-22465502-350F-486A-B980-39D7B12ED6D5Q40987315-270D92CD-9D95-4C3E-ACB9-BF9CF55CFBE2Q41246468-2F7B5069-CD33-4ED6-A1D0-F5859AD4ECD9Q41368108-3D473776-0EA5-4D71-B360-1313C7B6EF3EQ41523775-EF42B80B-8685-462C-B66F-3A6C286BCC6FQ41536966-5916D0BA-9D93-4FEC-A74F-36099718ECB7Q41761161-91404BBE-C893-49C5-9E8D-AB7888F0F7CDQ42330852-3C1A7D17-0588-491B-A012-30C88C234E4EQ42583875-E15161F1-45FD-44D2-A31C-1EAFCBE02DC1Q47627293-38BEB528-E40C-4A5A-8493-3283332AE8E9Q49859387-C9C01001-048D-4BE0-9C73-835096BBEE71Q52597964-1203484C-140B-4EB2-96F6-E5587C75A287Q57208195-6F2B4164-A76F-4D4C-BB3C-674020A08B67
P2860
Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Value of severity scales in pr ...... atic review and meta-analysis.
@ast
Value of severity scales in pr ...... atic review and meta-analysis.
@en
Value of severity scales in pr ...... atic review and meta-analysis.
@nl
type
label
Value of severity scales in pr ...... atic review and meta-analysis.
@ast
Value of severity scales in pr ...... atic review and meta-analysis.
@en
Value of severity scales in pr ...... atic review and meta-analysis.
@nl
prefLabel
Value of severity scales in pr ...... atic review and meta-analysis.
@ast
Value of severity scales in pr ...... atic review and meta-analysis.
@en
Value of severity scales in pr ...... atic review and meta-analysis.
@nl
P2093
P356
P1433
P1476
Value of severity scales in pr ...... matic review and meta-analysis
@en
P2093
Alagaratnam Niruban
Phyo K Myint
Yoon K Loke
P304
P356
10.1136/THX.2009.134072
P407
P577
2010-08-20T00:00:00Z